Vaxxel

Description: Vaxxel develops live-attenuated vaccines for bronchiolitis & pneumonia, targeting hMPV & respiratory viruses. Spin-off from Virpath, UCBL Lyon.

Country: France

Based in: Villeurbanne

Founded: 2019

Funding Stage: Pre-Seed

Tags: ['Pharmaceutical']

Categories

Add insights to your inbox

We’ll send you content you’ll want to read- and put to use.

Details about how we process your information are available in our Privacy Policy.